Seeking Alpha

Amylin Pharmaceuticals (AMLN +13.5%) is among the early leaders after an injectable diabetes...

Amylin Pharmaceuticals (AMLN +13.5%) is among the early leaders after an injectable diabetes drug being developed along with partners Eli Lilly (LLY +0.7%) and Alkermes (ALKS +3.3%) receives a positive opinion from an EU panel. European regulators are expected to make a final decision within 2-3 months. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)